Alpha Tau Medical Ltd. Proceeds from Sale of Restricted Investments
Alpha Tau Medical Ltd. (DRTS) reported Proceeds from Sale of Restricted Investments of $30.28 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-28.
Discontinued › Cash Flow
us-gaap:ProceedsFromSaleOfRestrictedInvestments · last filed 2022-03-28
| Period end | Proceeds from Sale of Restricted Investments 12 month |
|---|---|
| 2021-12-31 | $30.28M 20-F · filed 2022-03-28 |
| 2020-12-31 | $66.15M 20-F · filed 2022-03-28 |
| 2019-12-31 | $45.40M 20-F · filed 2022-03-28 |